glp 1 beta cell regeneration JCI Insight Harnessing beta cell regeneration biology

Liraglutide does not change bone turnover in clozapine- and olanzapine-treated schizophrenia overweight patients with prediabetesRandomized controlled trial

For instance, another recently completed trial by Eli Lilly investigated if people who were initially treated with an injectable GLP-1 drug could eventually transition to an oral version like Foundayo and still maintain the weight loss and health benefits

Glucagon and GLP-1 inhibit food intake and increase c-fos expression in similar appetite regulating centres in the brainstem and amygdala

In Covid-19, GIP response to the meal is impaired, leading to postprandial hyperglycemia and abnormal glucose homeostasis

Evaluating drug-drug interaction risk associated with peptide analogues using advanced in vitro systems